87
May2014
have top producers to economically utilise
this technology and thereby make a huge
contributions to food security.” After the
meetingDr Purchase said, in relation to the
presentations by the speakers, that he likes
Monsanto’s approach of integrated farming
systems to ensure optimal utilisation of
technology and resources.
“It just made me realise once again that
Monsanto is not only a genetics and seed
company, but that they look at the complete
sustainability of agriculture. I welcome
Monsanto’s commitment to make a bigger
difference in Africa to help and develop
the continent and its people,” concluded
Dr Purchase.
1: Jannie de Villiers (CEO: Grain SA) was
a guest speaker at Monsanto’s Global Key
Account Summit that was recently held
at Sun City. The aim of the summit was to
unite key account clients with each other
in order for them to network and to see
how we farm in South Africa. Some of the
international agricultural businesses also
came to investigate investment opportunities
inAfrica.
2:Onbehalf of SouthAfricangrainproducers,
Joseph du Plessis (Grain SA member of the
Executive) explained how we farm in South
Africa. On this photo he is in conversation
with Rob Dunlop of Monsanto, whowas also
a guest speaker at Grain SA’s Congress in
March this year.
3:JosephduPlessis (right) chats toproducers
from Bulgaria and Romania during a visit to
PetrusRouxnear Hoopstad.
4:HendrikvanStaden (Monsantokeyaccount
manager in South Africa) with Petrus Roux,
who farms near Hoopstad.
1
2
4
3
ArystaLifeScienceacquires French-based
company, Goëmar
SUPPLIEDBYARYSTA LIFESCIENCE
A
rysta LifeScience Limited has announced inMarch the ac-
quisition of the Goëmar group from BeCapital and Pechel
Industries. Goëmar isheadquartered inSaint-Malo, France,
and is a global manufacturer and supplier of biostimula-
tion, biocontrol and innovative nutrition for plants, including Physio
ActivatorTM andNatural Defense technologies.
This acquisition builds on Arysta LifeScience’s biosolutions plat-
form, originally developed from the Grupo Bioquímico Mexicano
(GBM) acquisition in 2007, along with their biocontrol portfolio,
Natural Plant Protection (NPP), with globally recognised products
such asAtonik®, Biozyme® andCarpovirusine®.
The two companies have already been working together to cross-
market their biosolutions offerings in Europe, in addition to several
commercial partnerships in high-growth countries, including India
andMexico.
Goëmar brings to Arysta LifeScience over 40 years of research
and technical expertise in biosolutions, with a broad portfolio of
highly differentiated products, cutting-edge innovation, and an in-
dustry-leading commercial organisation with complementary com-
petencies andgeographic reach.
“Arysta LifeScience’s objective is to strengthen its leadership posi-
tion in biosolutions, while also maximising the synergies with tra-
ditional crop protection solutions,” said Mr Wayne Hewett, CEO of
Arysta LifeScience. “The acquisition of Goëmar is a key pillar for
Arysta LifeScience’s continued growth in the rapidly expanding
biosolutions space, with an aligned vision and passion towards this
market.”
“Weareexcited to joinArystaLifeScienceand tocontinue toexecute
our vision towardsbioperformance leadership inagriculture,” added
Mr Jean-PierrePrincen, CEOof Goëmar.
“The complementary nature of the two enterprises will provide ad-
ditional capabilities to continue the tremendous growthwe have ex-
perienced over the recent years. In addition, the combined strength
of the two portfolios in biostimulation and biocontrol, establishes a
leadingglobal player in thesedynamic andgrowing segments.”
